Clinical Trial

A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The Goal of these study is to assess the comparative pharmacokinetics of Test Product (A): ADL-018 Injection 150 mg/mL solution in a single dose pre-filled autoinjector, manufactured by Kashiv Biosciences LLC, USA with Reference Product (B): ADL-018 Injection 150mg/mL solution in a single dose pre-filled syringe manufactured by Kashiv Biosciences LLC, USA in healthy, adult human subjects. and also to assess safety and tolerability of investigational product.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-08; most recent amendment 2026-02-18.
Status change: Recruiting → Completed 2026-01-16
Trial Details
NCT Number NCT06929052
Lead Sponsor Kashiv BioSciences, LLC
Conditions Healthy Adult Subjects
Enrollment 150 participants
Start Date 2025-01-29
Primary Completion 2025-08-15 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-20